Early Access — free while we kick the tires
EdgarHawk

Shaner Jeff

Chief Executive Officer

Officer
2 filings analyzed · 1 company · Latest 2026-02-19

Companies

Company Buys Sells Direction
Aveanna Healthcare Holdings, Inc. AVAH 0 6 Net selling

Activity

February 2026
Sell
461,909 shares
$3,411,399
Significance 6/10

CEO Shaner Jeff sold 461,909 shares in 3 tranches (Feb 17-19) for $3,411,399.14, reducing stake 14.8%; stock down 18.7% in 30 days post-transaction

CEO Jeff Shaner executed 3 separate sales totaling 461,909 shares for $3,411,399.14 between 2026-02-17 and 2026-02-19, reducing his holdings from 3,112,801 shares to 2,650,892 shares. The stock has declined 18.7% over the subsequent 30 days from the transaction prices (blended at $7.39), now trading at $7.42. The company reports full-year net income was negative despite positive quarterly revenue of $621,942,000.00 and modest 6.8% annual revenue growth; the P/E of 20.61 reflects a valuation applied to thin profitability. The timing of this multi-tranche liquidation—occurring at a price point that has since been exceeded by the 52-week high of $10.27—follows a pattern of prior same-ticker sells at AVAH, though 90-day outcome data remain incomplete for those trades. The sale size represents a material reduction in the CEO's post-transaction holdings and follows consecutive sales throughout late January and early February.

January 2026
Sell
84,960 shares
$689,985
Significance 5/10

CEO Jeff Shaner sold 84,960 shares of AVAH across 3 transactions (Dec 30–Jan 2) for $689,984.76 at blended avg $8.12.

CEO Jeff Shaner executed 3 separate sales totaling 84,960 shares for $689,984.76 at a blended average price of $8.12, reducing his holdings from 2.48M to 2.39M shares (-3.4%). The sales occurred at prices ($8.36, $8.18, $7.85) near but above the current price of $8.08, while the stock trades -21.3% below its 52-week high and has declined 9.2% over the past 30 days. AVAH reported quarterly revenue of $621.9M with net income of $14.1M, but the company was unprofitable on a full-year basis, yet maintains a P/E of 22.44 and $1.7B market cap. The sale size represents a modest portfolio reduction for a CEO holding 2.39M shares post-transaction, with no public data on whether this was discretionary or part of a scheduled plan.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access